109 related articles for article (PubMed ID: 6787063)
21. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
Cook DM; Greer MA; Paxton H
West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
[TBL] [Abstract][Full Text] [Related]
22. [The value of hyperprolactinemia determination within the scope of galactorrhea].
Schurz B; Enzelsberger H; Kubista E; Wenzl R
Zentralbl Gynakol; 1989; 111(1):33-8. PubMed ID: 2493708
[TBL] [Abstract][Full Text] [Related]
23. [Lack of diagnostic value of pharmacodynamic tests in the differential diagnosis of hyperprolactinemia (author's transl)].
Pineda G; Olmos P
Rev Med Chil; 1981 Sep; 109(9):830-2. PubMed ID: 6805062
[No Abstract] [Full Text] [Related]
24. In vivo effects of progestins on prolactin secretion.
Sitruk-Ware R; Varin C; Clair F; Maugis E; Fermanian J; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Mar; 60(3):575-8. PubMed ID: 3919048
[TBL] [Abstract][Full Text] [Related]
25. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
26. Isolated prolactin deficiency in a woman with puerperal alactogenesis.
Kauppila A; Chatelain P; Kirkinen P; Kivinen S; Ruokonen A
J Clin Endocrinol Metab; 1987 Feb; 64(2):309-12. PubMed ID: 3098774
[TBL] [Abstract][Full Text] [Related]
27. Biochemical diagnosis of pralactinoma.
Cowden EA; Ratcliffe JG; Thomson JA; Macpherson P; Doyle D; Teasdale GM
Lancet; 1979 Aug; 2(8136):256-7. PubMed ID: 89374
[No Abstract] [Full Text] [Related]
28. Establishment of reference values for endocrine tests. II: Hyperprolactinemia.
Le Moli R; Endert E; Fliers E; Mulder T; Prummel MF; Romijn JA; Wiersinga WM
Neth J Med; 1999 Aug; 55(2):71-5. PubMed ID: 10474275
[TBL] [Abstract][Full Text] [Related]
29. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
30. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
Gerasimov G; Chernova T; Goncharov N
Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
[TBL] [Abstract][Full Text] [Related]
31. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
[TBL] [Abstract][Full Text] [Related]
32. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
Seki K; Kato K
J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450
[TBL] [Abstract][Full Text] [Related]
33. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
34. The effect of prolonged lithium carbonate administration on the thyrotrophin and prolactin response to thyrotrophin-releasing hormone.
Epstein S; Sagel J; Zabow T; Pimstone B; Vinik A
S Afr Med J; 1975 Nov; 49(47):1977-9. PubMed ID: 812185
[TBL] [Abstract][Full Text] [Related]
35. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
[TBL] [Abstract][Full Text] [Related]
36. Hyperthyroidism, inappropriate plasma TSH and pituitary adenoma in three patients, two receiving long-term phenothiazine therapy.
Dunne FP; Feely MP; Ferriss JB; Keohane C; Murphy D; Perry I
Q J Med; 1990 Apr; 75(276):345-54. PubMed ID: 2117296
[TBL] [Abstract][Full Text] [Related]
37. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
38. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
Arafah BM; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
[TBL] [Abstract][Full Text] [Related]
40. Clomiphene attenuates the exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide occurring in primary testicular failure.
Spitz IM; Halperin Y; Shilo S; LeRoith D; Zylber-Haran E; Livshin Y; Laufer N; Schenker J
J Clin Endocrinol Metab; 1981 Feb; 52(2):289-93. PubMed ID: 6780589
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
